Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2022

Open Access 01-12-2022 | Itraconazole | Case report

Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report

Authors: Fatemeh Mohaghegh, Bahareh Abtahi-Naeini, Elahe Nasri, Parisa Badiee, Hamid Morovati, Hamed Fakhim, Aida Farmani, Mohsen Meidani, Maryam Ranjbar-Mobarake, Rasoul Mohammadi

Published in: Journal of Medical Case Reports | Issue 1/2022

Login to get access

Abstract

Background

Fusarium species are saprophytic fungi with a worldwide distribution. These fungi cause various infections among immunocompromised patients; however, they can also involve immunocompetent individuals.

Case presentation

We report a case of a 41-year-old Iranian woman who presented with ulcerative lesions on her lips 10 months ago. She had a long history of anxiety but had no history of classical risk factors such as trauma, cosmetic lip tattoo, burning in her lips, smoking or use of alcohol and opium. A skin biopsy from the lower lip was performed and sent for microbiological examinations. Hyaline septate hyphae were seen on direct microscopy with potassium hydroxide. The clinical specimen was subcultured on sabouraud dextrose agar with chloramphenicol and prepared for antifungal susceptibility testing and molecular identification. Considering the minimum inhibitory concentrations (MIC) for antifungals, itraconazole (100 mg orally twice a day) was started for her, and after 2 months, the lesions were treated. She followed up for 3 months, and no signs of disease recurrence were observed.

Conclusions

Selecting an appropriate treatment strategy according to the laboratory assessments is essential in clinical practice and the management of rare infections to prevent related mortality and morbidity of opportunistic fungal infections.
Literature
1.
go back to reference Tortorano A, Prigitano A, Esposto M, Arsic Arsenijevic V, Kolarovic J, Ivanovic D, et al. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis. 2014;33:1623–30.CrossRef Tortorano A, Prigitano A, Esposto M, Arsic Arsenijevic V, Kolarovic J, Ivanovic D, et al. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis. 2014;33:1623–30.CrossRef
2.
go back to reference Chae SY, Park HM, Oh TH, Lee JE, Lee HJ, Jeong WG, et al. Fusarium species causing invasive fungal pneumonia in an immunocompetent patient: a case report. J Int Med Res. 2020;48:300060520976475.CrossRef Chae SY, Park HM, Oh TH, Lee JE, Lee HJ, Jeong WG, et al. Fusarium species causing invasive fungal pneumonia in an immunocompetent patient: a case report. J Int Med Res. 2020;48:300060520976475.CrossRef
3.
go back to reference Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20:695–704.CrossRef Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20:695–704.CrossRef
4.
go back to reference Bodey GP, Boktour M, Mays S, Duvic M, Kontoyiannis D, Hachem R, et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002;47:659–66.CrossRef Bodey GP, Boktour M, Mays S, Duvic M, Kontoyiannis D, Hachem R, et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002;47:659–66.CrossRef
5.
go back to reference Clinical laboratory standards institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, 3rd ed; approved standard. CLSI document M38. Wayne: Clinical and laboratory standards institute; 2017. Clinical laboratory standards institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, 3rd ed; approved standard. CLSI document M38. Wayne: Clinical and laboratory standards institute; 2017.
6.
go back to reference White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR Protoc Guide Methods Appl. 1990;18:315–22. White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. PCR Protoc Guide Methods Appl. 1990;18:315–22.
7.
go back to reference Gupta AK, Baran R, Summerbell RC. Fusarium infections of the skin. Curr Opin Infect Dis. 2000;13:121–8.CrossRef Gupta AK, Baran R, Summerbell RC. Fusarium infections of the skin. Curr Opin Infect Dis. 2000;13:121–8.CrossRef
8.
go back to reference Radulesco T, Varoquaux A, Ranque S, Dessi P, Michel J, Cassagne C. Maxillary fungus balls due to Fusarium proliferatum. J Mycol Med. 2019;29:59–61.CrossRef Radulesco T, Varoquaux A, Ranque S, Dessi P, Michel J, Cassagne C. Maxillary fungus balls due to Fusarium proliferatum. J Mycol Med. 2019;29:59–61.CrossRef
9.
go back to reference Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis. 2002;35:909–20.CrossRef Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis. 2002;35:909–20.CrossRef
10.
go back to reference Ferrer C, Alio J, Rodriguez A, Andreu M, Colom F. Endophthalmitis caused by Fusarium proliferatum. J Clin Microbiol. 2005;43:5372–5.CrossRef Ferrer C, Alio J, Rodriguez A, Andreu M, Colom F. Endophthalmitis caused by Fusarium proliferatum. J Clin Microbiol. 2005;43:5372–5.CrossRef
11.
go back to reference Aspiroz C, Sevil M, Toyas C, Gilaberte Y. Photodynamic therapy with methylene blue for skin ulcers infected with Pseudomonas aeruginosa and Fusarium spp. Actas Dermosifiliogr. 2017;108:e45–8.CrossRef Aspiroz C, Sevil M, Toyas C, Gilaberte Y. Photodynamic therapy with methylene blue for skin ulcers infected with Pseudomonas aeruginosa and Fusarium spp. Actas Dermosifiliogr. 2017;108:e45–8.CrossRef
12.
go back to reference Al-Hatmi AMS, Curfs-Breuker I, de Hoog GS, Meis JF, Verweij PE. Antifungal susceptibility testing of fusarium: a practical approach. J Fungi (Basel). 2017;3:19.CrossRef Al-Hatmi AMS, Curfs-Breuker I, de Hoog GS, Meis JF, Verweij PE. Antifungal susceptibility testing of fusarium: a practical approach. J Fungi (Basel). 2017;3:19.CrossRef
13.
go back to reference Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006;50:917–21.CrossRef Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006;50:917–21.CrossRef
14.
go back to reference Tzatzarakis M, Tsatsakis A, Charvalos E, Vakalounakis D. Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum. J Environ Sci Health. 2001;36:331–40.CrossRef Tzatzarakis M, Tsatsakis A, Charvalos E, Vakalounakis D. Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum. J Environ Sci Health. 2001;36:331–40.CrossRef
15.
go back to reference Nucci M, Jenks J, Thompson GR, Hoenigl M, Dos Santos MC, Forghieri F, et al. Do high MICs predict the outcome in invasive fusariosis? J Antimicrob Chemother. 2021;12(76):1063–9.CrossRef Nucci M, Jenks J, Thompson GR, Hoenigl M, Dos Santos MC, Forghieri F, et al. Do high MICs predict the outcome in invasive fusariosis? J Antimicrob Chemother. 2021;12(76):1063–9.CrossRef
16.
go back to reference Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Clin Exp Dermatol. 2010;35:658–63.CrossRef Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Clin Exp Dermatol. 2010;35:658–63.CrossRef
17.
go back to reference Silva LB, de Oliveira DB, da Silva BV, de Souza RA, da Silva PR, Ferreira-Paim K, et al. Identification and antifungal susceptibility of fungi isolated from dermatomycoses. J Eur Acad Dermatol Venereol. 2014;28:633–40.CrossRef Silva LB, de Oliveira DB, da Silva BV, de Souza RA, da Silva PR, Ferreira-Paim K, et al. Identification and antifungal susceptibility of fungi isolated from dermatomycoses. J Eur Acad Dermatol Venereol. 2014;28:633–40.CrossRef
18.
go back to reference Al-Hatmi AM, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, Meis JF. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. J Antimicrob Chemother. 2015;70:1068–71.PubMed Al-Hatmi AM, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, Meis JF. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. J Antimicrob Chemother. 2015;70:1068–71.PubMed
Metadata
Title
Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report
Authors
Fatemeh Mohaghegh
Bahareh Abtahi-Naeini
Elahe Nasri
Parisa Badiee
Hamid Morovati
Hamed Fakhim
Aida Farmani
Mohsen Meidani
Maryam Ranjbar-Mobarake
Rasoul Mohammadi
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Itraconazole
Published in
Journal of Medical Case Reports / Issue 1/2022
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-022-03575-5

Other articles of this Issue 1/2022

Journal of Medical Case Reports 1/2022 Go to the issue